| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/13/2006 | CN1274691C Two new compounds for treating impotence |
| 09/13/2006 | CN1274668C Salts of nateglinide |
| 09/13/2006 | CN1274329C Paster for regulating menstruation and relieving pain |
| 09/13/2006 | CN1274328C Chinese medicine for sexual impotence and its production |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105523 Carbamate-substituted pyrazolopyridine-derivatives |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105490 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105489 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105487 Animals are injected with an injection solution that contains synthetically produced FSH-releasing hormones with known sequences consisting of 10 amino acids (decapeptide) |
| 09/12/2006 | CA2346539C Compositions and methods for enhancing receptor-mediated cellular internalization |
| 09/08/2006 | WO2006093853A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093110A1 Nitroguanosine-3’,5’-cyclic monophosphate and protein kinase g activator |
| 09/08/2006 | WO2006092731A1 1, 2, 4-triazole derivatives and their use as oxytocin antagonists |
| 09/08/2006 | WO2006092710A1 Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione |
| 09/08/2006 | WO2006030306A3 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 09/08/2006 | WO2005105103A3 Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| 09/08/2006 | CA2599588A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
| 09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199818 Inhibiting the activity of a 5-hydroxytryptamine 2A by administering a N-heterocyclyl (preferably 1,3-dioxan-5-yl)-4-[(N-substituted)(hetero)arylamino]piperidine in which the N-substituant is arylalkanoyl, arylthioalkanoyl, arylalkylaminocarbonyl or arylalkylaminothiocarbonyl group |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | DE102005009241A1 Arzneiformen mit kontrollierter Bioverfügbarkeit Dosage forms with controlled bioavailability |
| 09/07/2006 | DE102005009240A1 Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften Dosage forms with improved pharmacokinetic properties |
| 09/06/2006 | EP1698639A2 Pluripotency determining factors and uses thereof |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698335A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 09/06/2006 | EP1697356A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
| 09/06/2006 | EP1525215B1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 09/06/2006 | EP1453520B1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP1112075B1 Compositions for the treatment of male erectile dysfunction |
| 09/06/2006 | CN1829731A Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof |
| 09/06/2006 | CN1829510A Dispersible formulation of an anti-inflammatory agent |
| 09/06/2006 | CN1827161A Method for preparing trichosanthin injection |
| 09/06/2006 | CN1827159A Menstruation-regulating preparation and novel method for preparing the same |
| 09/06/2006 | CN1827158A Compound forming agent with zedoary turmeric oil and method for preparing the same |
| 09/06/2006 | CN1827151A Chinese medicinal preparation for treating sterility, its preparation and quality control method |
| 09/06/2006 | CN1827136A Compound Chinese medicinal preparation for treating male sterility |
| 09/06/2006 | CN1827131A Medicinal composition for treating dysmenorrhea and preparation method thereof |
| 09/06/2006 | CN1827128A Vaginal administered medicament with honeysuckle, baikal skullcap root and forsythia fruit and method for preparing the same |
| 09/06/2006 | CN1827124A Dripping pills of herba lamiophlomis rotatae and method for preparing the same |
| 09/06/2006 | CN1827117A Sustained release medicament of compound gossypol acetate |
| 09/06/2006 | CN1827105A Foaming agent for treating gynecological disease and method for preparing the same |
| 09/06/2006 | CN1827087A Foaming agent of nonoxynol and method for preparing the same |
| 09/06/2006 | CN1827086A Foaming agent of povidone iodine and method for preparing the same |
| 09/06/2006 | CN1273493C Angelica polysaccharide and its preparation and use |
| 09/06/2006 | CN1273469C Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 09/06/2006 | CN1273460C Benzofuran and benzothiophene derivatives |
| 09/06/2006 | CN1273446C Bearing-resisting compound and preparing method |
| 09/06/2006 | CN1273170C Capsule of Chinese traditional medicine for treating diseases caused by insufficiency of kidney-yang and deficiency of blood |
| 09/06/2006 | CN1273161C Oral liquid for treating acute mastitis |
| 09/06/2006 | CN1273158C Traditional Chinese medicine for resisting abortion and its preparing process |
| 09/06/2006 | CN1273151C Capsules for treating menopausal syndrome |
| 09/06/2006 | CN1273141C Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate and preparation method thereof |
| 09/06/2006 | CN1273134C Soft capsule of fibrauretine and preparation method thereof |
| 09/06/2006 | CN1273132C Aromatase inhibitor |
| 09/06/2006 | CN1273111C Compound gel of flavescent sophora root and black catechu and its preparation method |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/02/2006 | CA2498639A1 Niacin used as oral supplementation for the treatment and prevention of sexual dysfunction in human males and females |
| 08/31/2006 | WO2006091769A1 Novel quinoline derivatives as potassium ion channel openers |
| 08/31/2006 | WO2006090850A1 Benzamide compound |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006065555A3 Use of alpha-adrenergic blockers for the treatment of dysmenorrhea |
| 08/31/2006 | WO2005092441A3 Extended cycle multiphasic oral contraceptive method |
| 08/31/2006 | US20060194854 New 2-substituted - 1,3-thiazole compounds |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194780 N-Azacycloalkylcarbonyl-substituted bicyclic piperidines, e.g., N-tert-butyl)-8-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}-3-cyclohexyl-8-azabicyclo[3.2.1]octane-3-carboxamide; useful for treating obesity, diabetes, and sexual dysfunction |
| 08/31/2006 | US20060193929 Method for treating or preventing symptoms associated with menopause |
| 08/31/2006 | US20060193927 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2599151A1 Novel quinoline derivatives as potassium ion channel openers |
| 08/30/2006 | EP1695980A2 Human papillomavirus E2 transactivation domain / inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 08/30/2006 | EP1695976A1 Pyrazolopyrimidinethione derivatives, salts and solvates thereof, preparation methods and use thereof |
| 08/30/2006 | EP1694332A2 Treatment of sexual disorders |
| 08/30/2006 | EP1383772B1 Nitrogen-based camptothecin derivatives |
| 08/30/2006 | EP1377298B1 Exemestane for treating hormono-dependent disorders |
| 08/30/2006 | EP1322660B1 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 08/30/2006 | CN1826135A Unitary combinations of FSH and hCG |
| 08/30/2006 | CN1826107A Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator |
| 08/30/2006 | CN1826059A Composition containing lactic acid bacterium producing equol |
| 08/30/2006 | CN1824758A Deer wine and its production method |
| 08/30/2006 | CN1824312A Compound medicine for preventing and treating cardio vascular cerebral vascular disease and its application |
| 08/30/2006 | CN1824269A Xinshenghua oral liquid and its preparation method |
| 08/30/2006 | CN1824268A Spken invigorating qi replenishing dispersion solid medicinal preparation and its manufacturing method |
| 08/30/2006 | CN1824259A Chinese medicinal preparation for treating woman menstrual pain and its preparation method |
| 08/30/2006 | CN1824258A Quality control method of fuyuekang Chinese medicinal preparation |